80574 Federal Register / Vol. 89, No. 192 / Thursday, October 3, 2024 / Notices 

required. Please visit the ACHDNC 

website for information on registration: 

https://www.hrsa.gov/advisorycommittees/heritable-disorders/ 

index.html. Register no later than 12:00 

p.m. ET on November 13, 2024. 

Instructions on how to access the 

meeting via webcast will be provided 

upon registration. 

FOR FURTHER INFORMATION CONTACT: 

Leticia Manning, Maternal and Child 

Health Bureau, HRSA, 5600 Fishers 

Lane, Room, Rockville, Maryland 20857; 

301–443–8335; or ACHDNC@hrsa.gov. 

SUPPLEMENTARY INFORMATION: ACHDNC 

provides advice and recommendations 

to the Secretary of Health and Human 

Services (Secretary) on the development 

of newborn screening activities, 

technologies, policies, guidelines, and 

programs for effectively reducing 

morbidity and mortality in newborns 

and children having, or at risk for, 

heritable disorders. ACHDNC reviews 

and reports regularly on newborn and 

childhood screening practices, 

recommends improvements in the 

national newborn and childhood 

screening programs, and fulfills 

requirements stated in the authorizing 

legislation. In addition, ACHDNC’s 

recommendations regarding inclusion of 

additional conditions for screening on 

the Recommended Uniform Screening 

Panel, following adoption by the 

Secretary, are evidence-informed 

preventive health services provided for 

in the comprehensive guidelines 

supported by HRSA pursuant to section 

2713 of the Public Health Service Act 

(42 U.S.C. 300gg–13). Under this 

provision, non-grandfathered group 

health plans and health insurance 

issuers offering non-grandfathered 

group or individual health insurance are 

required to provide insurance coverage 

without cost-sharing (a co-payment, coinsurance, or deductible) for preventive 

services for plan years (i.e., policy years) 

beginning on or after the date that is 1 

year from the Secretary’s adoption of the 

condition for screening. 

During the November 14, 2024, 

meeting, ACHDNC will hear from 

experts in the fields of public health, 

medicine, heritable disorders, rare 

disorders, and newborn screening. 

Possible agenda items may include the 

following topics: 

(1) An update on the development of 

a newborn screening family outcomes 

tool, 

(2) A panel presentation on funding 

opportunities for research that includes 

the lived experience, 

(3) A presentation on the Newborn 

Screening Information Center, and 

(4) An update on Recommended 

Uniform Screening Panel condition 

nomination submissions. 

Agenda items are subject to change as 

priorities dictate. Information about 

ACHDNC, including a roster of members 

and past meeting summaries, is 

available on the ACHDNC website listed 

above. 

Members of the public will have the 

opportunity to provide comments on 

any of the above agenda items. Public 

participants may request to provide 

general oral comments and may submit 

written statements in advance of the 

scheduled meeting. Oral comments will 

be honored in the order they are 

requested and may be limited as time 

allows. Requests to provide a written 

statement or make oral comments to 

ACHDNC must be submitted via the 

registration website by 12:00 p.m. ET on 

Thursday, October 31, 2024. Written 

comments will be shared with the 

Committee prior to the meeting so they 

have an opportunity to consider them in 

advance of the meeting. 

Individuals who need special 

assistance or another reasonable 

accommodation should notify Leticia 

Manning at the address and phone 

number listed above at least 10 business 

days prior to the meeting. 

Maria G. Button, 

Director, Executive Secretariat. 

[FR Doc. 2024–22733 Filed 10–2–24; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Charter Renewal of the Presidential 

Advisory Council on Combating 

Antibiotic-Resistant Bacteria 

AGENCY: Office of the Assistant 

Secretary for Health, Office of the 

Secretary, Department of Health and 

Human Services. 

ACTION: Notice. 

SUMMARY: As stipulated by the Federal 

Advisory Committee Act, the 

Department of Health and Human 

Services (HHS) is hereby giving notice 

that the charter for the Presidential 

Advisory Council on Combating 

Antibiotic-Resistant Bacteria 

(PACCARB) has been renewed. 

FOR FURTHER INFORMATION CONTACT: 

Jomana Musmar, M.S., Ph.D., 

Designated Federal Officer, Presidential 

Advisory Council on Combating 

Antibiotic-Resistant Bacteria, Office of 

the Assistant Secretary for Health, U.S. 

Department of Health and Human 

Services, 1101 Wootton Parkway, 

Rockville, MD 20852. Phone: 202–746– 

1512; Email: CARB@hhs.gov. 

SUPPLEMENTARY INFORMATION: The 

Presidential Advisory Council on 

Combating Antibiotic-Resistant Bacteria 

(PACCARB), established by Executive 

Order 13676, is continued by section 

505 of Public Law 116–22, the 

Pandemic and All-Hazards 

Preparedness and Advancing Innovation 

Act of 2019 (PAHPAIA). Activities and 

duties of the PACCARB are governed by 

the provisions of the Federal Advisory 

Committee Act (FACA), Public Law 92– 

463, as amended (5 U.S.C. app.), which 

sets forth standards for the formation 

and use of Federal advisory committees. 

FACA stipulates that the charter for a 

Federal advisory committee must be 

renewed every two years. 

The PACCARB shall advise and 

provide information and 

recommendations to the Secretary of 

Health and Human Services (Secretary) 

regarding programs and policies 

intended to reduce or combat antibioticresistant bacteria that may present a 

public health threat and improve 

capabilities to prevent, diagnose, 

mitigate, or treat such resistance. The 

PACCARB shall function solely for 

advisory purposes. 

Such advice, information, and 

recommendations may be related to 

improving: the effectiveness of 

antibiotics; research and advanced 

research on, and the development of, 

improved and innovative methods for 

combating or reducing antibiotic 

resistance, including new treatments, 

rapid point-of-care diagnostics, 

alternatives to antibiotics, including 

alternatives to animal antibiotics, and 

antimicrobial stewardship activities; 

surveillance of antibiotic-resistant 

bacterial infections, including publicly 

available and up-to-date information on 

resistance to antibiotics; education for 

health care providers and the public 

with respect to up-to-date information 

on antibiotic resistance and ways to 

reduce or combat such resistance to 

antibiotics related to humans and 

animals; methods to prevent or reduce 

the transmission of antibiotic-resistant 

bacterial infections; including 

stewardship programs; and coordination 

with respect to international efforts in 

order to inform and advance the United 

States capabilities to combat antibiotic 

resistance. 

On August 29, 2024, the Secretary of 

Health and Human Services approved 

the renewal of the PACCARB’s charter. 

The new charter was executed and filed 

with the appropriate Congressional 

committees and the Library of Congress 

on August 29, 2024. The renewal of the 


ddrumheller on DSK120RN23PROD with NOTICES1
Federal Register / Vol. 89, No. 192 / Thursday, October 3, 2024 / Notices 80575 

charter gives the PACCARB 

authorization to operate until August 

29, 2026. 

A copy of the charter is available on 

the PACCARB’s website at: 

www.hhs.gov/paccarb. 

Dated: September 26, 2024. 

B. Kaye Hayes, 

Director, Office of Infectious Disease and HIV/ 

AIDS Policy, Office of the Assistant Secretary 

for Health. 

[FR Doc. 2024–22794 Filed 10–2–24; 8:45 am] 

BILLING CODE 4150–44–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Advisory Council on Alzheimer’s 

Research, Care, and Services; Meeting 

AGENCY: Assistant Secretary for 

Planning and Evaluation, HHS. 

ACTION: Notice of meeting. 

SUMMARY: This notice announces the 

public meeting of the Advisory Council 

on Alzheimer’s Research, Care, and 

Services (Advisory Council). The 

Advisory Council provides advice on 

how to prevent or reduce the burden of 

Alzheimer’s disease and related 

dementias on people with the disease 

and their caregivers. During the 

meeting, the Advisory Council will hear 

updates from federal agencies on 

activities during the last quarter and 

from panels organized by the clinical 

care and risk reduction subcommittees. 

Presenters will discuss dementia care 

from different perspectives, including 

those of providers, people with lived 

experience, and CMMI GUIDE Model 

participants, as well as how to bridge 

gaps in service delivery. 

DATES: The meeting will be October 21, 

2024, from 9:30 a.m. to 4:30 p.m. 

ADDRESSES: The meeting will be a 

hybrid of in-person and virtual. The 

meeting will be held in Room 800 of the 

Hubert H. Humphrey Building, 200 

Independence Avenue SW, Washington, 

DC 20201. It will also stream live at 

www.hhs.gov/live. 

Comments: Time is allocated on the 

agenda to hear public comments from 

4:00 p.m. to 4:25 p.m. on Monday, 

October 21. The time for oral comments 

will be limited to two (2) minutes per 

individual. To provide a public 

comment, please register by emailing 

your name to napa@hhs.gov by 

Wednesday, October 16. Registered 

commenters will receive both a dial-in 

number and a link to join the meeting 

virtually; individuals will have the 

choice to either join virtually via the 

link, or to call in only by using the dialin number. Note: There may be a 30–45 

second delay in the livestream video 

presentation of the conference. For this 

reason, if you have pre-registered to 

submit a public comment, it is 

important to connect to the meeting by 

3:45 p.m. to ensure that you do not miss 

your name and allotted time when 

called. If you miss your name and 

allotted time to speak, you may not be 

able to make your public comment. 

Public commenters will not be admitted 

to the virtual meeting before 3:30 p.m. 

but are encouraged to watch the meeting 

at www.hhs.gov/live. Should you have 

questions during the session, please 

email napa@hhs.gov and someone will 

respond to your message as quickly as 

possible. 

To ensure accuracy, please submit a 

written copy of oral comments for the 

record by emailing napa@hhs.gov by 

Wednesday, October 23, 2024. These 

comments will be shared on the website 

and reflected in the meeting minutes. 

In lieu of oral comments, formal 

written comments may be submitted for 

the record by Wednesday, October 23, 

2024, to Helen Lamont, Ph.D., OASPE, 

200 Independence Avenue SW, Room 

424E, Washington, DC 20201. 

Comments may also be sent to napa@

hhs.gov. Those submitting written 

comments should identify themselves 

and any relevant organizational 

affiliations. 

FOR FURTHER INFORMATION CONTACT: 

Helen Lamont, 202–260–6075, 

helen.lamont@hhs.gov. Note: The 

meeting will be available to the public 

live at www.hhs.gov/live. 

SUPPLEMENTARY INFORMATION: Notice of 

these meetings is given under the 

Federal Advisory Committee Act 

(5 U.S.C. App. 2, section 10(a)(1) and 

(a)(2)). Topics of the Meeting: 

Alzheimer’s disease-related dementias, 

clinical care, risk reduction. 

Procedure and Agenda: The meeting 

will be webcast at www.hhs.gov/live and 

video recordings will be added to the 

National Alzheimer’s Project Act 

website when available after the 

meeting. This meeting is open to the 

public. Please allow 30 minutes to go 

through security and walk to the 

meeting room. Participants joining in 

person should note that seating may be 

limited. Those wishing to attend the 

meeting in person must send an email 

to napa@hhs.gov and put ‘‘October 21 

Meeting Attendance’’ in the subject line 

by Wednesday, October 16 so that their 

names may be put on a list of expected 

attendees and forwarded to the security 

officers at the Department of Health and 

Human Services. Any interested 

member of the public who is a non-U.S. 

citizen should include this information 

at the time of registration to ensure that 

the appropriate security procedure to 

gain entry to the building is carried out. 

Although the meeting is open to the 

public, procedures governing security 

and the entrance to Federal buildings 

may change without notice. If you wish 

to make a public comment, you must 

note that within your email. 

Authority: 42 U.S.C. 11225; Section 

2(e)(3) of the National Alzheimer’s 

Project Act. The panel is governed by 

provisions of Public Law 92–463, as 

amended (5 U.S.C. Appendix 2), which 

sets forth standards for the formation 

and use of advisory committees. 

Dated: September 17, 2024. 

Tisamarie B. Sherry, 

Deputy Assistant Secretary for Behavioral 

Health, Disability, and Aging Policy, 

performing the delegable duties of the 

Assistant Secretary for Planning and 

Evaluation. 

[FR Doc. 2024–22763 Filed 10–2–24; 8:45 am] 

BILLING CODE 4150–05–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Charter Renewal of the Secretary’s 

Advisory Committee on Human 

Research Protection 

AGENCY: Office for Human Research 

Protections, Office of the Assistant 

Secretary for Health, Office of the 

Secretary, Department of Health and 

Human Services. 

ACTION: Notice. 

SUMMARY: The Department of Health and 

Human Services is hereby giving notice 

that the charter for the Secretary’s 

Advisory Committee on Human 

Research Protection (SACHRP) has been 

renewed. 

FOR FURTHER INFORMATION CONTACT: Ms. 

Julia Gorey, Designated Federal Officer 

for the SACHRP, Office for Human 

Research Protections, 1101 Wootton 

Parkway, Rockville, MD 20852. Phone: 

(240) 453–8141; Email: SACHRP@

hhs.gov. 

SUPPLEMENTARY INFORMATION: SACHRP 

is a discretionary Federal advisory 

committee. SACHRP is authorized 

under 42 U.S.C. 217a, Section 222 of the 

Public Health Service (PHS) Act, as 

amended. The Committee is governed 

by the provisions of the Federal 

Advisory Committee Act (FACA), Public 

Law 92–463, as amended (5 U.S.C. app), 

which sets forth standards for the 

formation and use of advisory 

committees. 

SACHRP functions to provide advice 

to the Secretary, through the Assistant 

Secretary for Health, on matters 


ddrumheller on DSK120RN23PROD with NOTICES1